Učitavanje...

Absence of deletions but frequent loss of expression of p16INK4 in human ovarian tumours.

The cyclin-dependent kinase inhibitor p16 gene (P16, MTS1, CDKN2) has been shown to be altered by deletion or point mutation in some human tumours and cancer cell lines, suggesting that it works as a tumour suppressor. We analysed p16 gene mutation and p16 protein expression in 42 primary ovarian ca...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Marchini, S., Codegoni, A. M., Bonazzi, C., Chiari, S., Broggini, M.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1997
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2223926/
https://ncbi.nlm.nih.gov/pubmed/9231912
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!